SLAS 2012 : Advances in Drug and Life Sciences R&D Through Laboratory Technology

2012 SLAS Asia Conference and Exhibition

Advances in Drug and Life Sciences R&D Through Laboratory Technology

 

The Society for Laboratory Automation and Screening (SLAS) is once again hosting an important scientific conference in Shanghai. Join 350+ drug discovery research and development professionals, 19-21 June, to learn about new scientific laboratory trends and techniques, meet like-minded professionals and explore new products and technologies. The conference’s innovative, yet practical, curriculum ensures you will return to your lab with new ideas and information that will help you achieve your personal goals and professional success.

Keynote Speakers

Biochemical Pathway of Necrosis Xiaodong Wang, Ph.D. Director National Institute of Biological Science China

Primary and PSC Derived Cells for Screening Mahendra Rao, M.D., Ph.D. Director NIH Center for Regenerative Medicine USA

Closing Event
SLAS $10,000 Innovation Award Winner Dan Dongeun Huh, Ph.D. Harvard University, Boston, MA, headlines the closing session, which also includes three other finalists from the prestigious SLAS Innovation Award Competition. Huh will present his winning podium presentation: A Human Breathing Lung-on-a-Chip for Drug Screening and Nanotoxicology Applications

Optional Short Courses

·  Label-Free/Biophysics Methods for Screening

·  High Content Screening: Instrumentation, Assay Development, Screening, Image and Data Analysis

·  What Editors Want: An Author Guide to Publishing in Scientific Journals

﹡ Short Course I and Short Course II require additional registration fees

﹡ Short Course III is free for SLAS Asia Conference registered attendees

Who Should Attend

Conference participants will include academic, corporate and government scientists and engineers along with executive-level business professionals — all of whom share a common interest in advancing their understanding and expertise in laboratory science and technology. SLAS has a strong membership presence in drug discovery, including the disciplines of drug discovery testing (screening, assay development, data management, laboratory automation, etc.), system integration and miniaturization technologies.

Why You Should Attend

• 25+ accomplished speakers share recent achievements in life sciences research • 3 optional pre-conference full-day short courses offer in-depth exploration of focused topics • 6 exhibitor tutorials demonstrate how to put new techniques and technologies to work for you • 30+ poster presentations highlight innovative research projects • 40+ multinational companies exhibit the latest in laboratory technologies and automation • 350+ like-minded drug discovery research and development professionals

How to Attend

Register before 23 April for EARLY BIRD discounts! Tel: 86-21-51081565, Fax: 86-21-51160275 E-mail: Registration@asia-slas.org For more conference information, please visit: www.asia-slas.org/conference

Session 1: Drug Discovery Technologies

Co-Chairs: Bin Li, Ph.D., R&D Director, Abbott R&D Center, China
                  Zhijie Liu, Ph.D., Professor, Institute of Biophysics, CAS, China

 

·	Leveraging the Power of High-Throughput Screening to Accelerate Profiling and Target Identification Daniel Sipes, M.S., Director of Advanced Automation Technologies, Genomics Institute of the Novartis Research Foundation, USA
·	A Personal Platform for High-Throughput Screening: Versatile Application of the Thermal Shift Assay to Multiple Stages of Early Lead Discovery Kenneth M. Comess, Ph.D., Senior Scientist III, Abbott Laboratories, Lead Discovery, USA
·	Generation and Analysis of Large Natural Product Compound Libraries for Drug Discovery Jinfeng Hu, Ph.D., Professor and Head of Dept. Natural Products Chemistry, School of Pharmacy, Fudan University, China
·	How to Build a Centralized Compound Management Function in GlaxoSmithKline R&D China Ying Huang, M.S., Head of Compound Management, GlaxoSmithKline R&D, China

Session 2: From Screening to Therapy

Co-Chairs: Qiang Lu, Ph.D., VP Biology Discovery, Wuxi Apptec, China

                  Lusong Luo, Ph.D., Head of Discovery Biology, Beigene, China

·	Discover Novel Fusion Inhibitors for Influenza Virus Jim Wu, Ph.D., Senior Director, Roche Pharma Research and Early Development China
·	Lessons Learned from Oncology Drug Discovery Lusong Luo, Ph.D., Head of Discovery Biology, Beigene, China
·	High Content Screening of ncRNA Libraries Biju(Bill) Zhang, Ph.D., CSO, Guangzhou, RiboBio, China
·	High-Throughput Kinase Profiling Strategy as A Way to Accelerate Anti-cancer Drug Discovery Ming Yan,Ph.D., Assistant Research Fellow, China Pharmaceutical University, China

Session 3: Stem Cells in Drug Discovery

 

Co-Chairs: Xin Xie,Ph.D., Professor, Deputy Director, National Center for Drug Screening, China

             Wei Zheng, Ph.D., Group Leader, National Center for Advancing Translational Sciences, NIH, USA

·	Reprogramming under Optimized Conditions Reveals a Shortened Route to Pluripotency Duanqing Pei, Ph.D., Professor and Director General, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Science, China
·	Application of iPSC Derived Human Neurons for Evaluation of Drug Efficacy and Neuronal Toxicity Wei Zheng, Ph.D., Group Leader, National Center for Advancing Translational Sciences, NIH, USA
·	Developing Screens in Human Pluripotent Stem Cells Xianmin Zeng, Ph.D., Associate Professor and Director, CIRM Shared Research Laboratory for Stem Cells & Aging; Buck Institute for Research on Aging, USA
·	Using Human Pluripotent Stem Cells to Pave the Way to Drug Discovery Yi Sun, Ph.D., Professor, Stem Cell Research Center, Tongji University, Translational Center for Stem Cell Research, Tongji Hospital

Closing Event: SLAS Innovation Award Finalists

Chair: Zhong Zhong, Ph.D., Director, Discovery Technologies, GlaxoSmithKline R&D China

·	Tissue Dynamics Imaging for Phenotypic Profiling in Drug Screening David Nolte, Ph.D., Professor, Purdue University, West Lafayette, IN, USA
·	New Platform Technology for Simple, Consistent Production of Collagen Based Tissues for Physiologically Relevant Assays Rosemary Drake, Ph.D., Chief Scientific Officer, TAP Biosystems, United Kingdom
·	Partipetting and Spinning Color Barcoded Microparticles for Ultraplex Bio-assay Sunghoon Kwon, Ph.D., Assistant Professor, School of Electrical Engineering, Seoul National University, South Korea
·	A Human Breathing Lung-on-a-Chip for Drug Screening and Nanotoxicology Applications Dan Dongeun Huh, Ph.D., Wyss Technology Development Fellow & Research Associate, Harvard University, USA

 

Exhibit Space 80% Sold!

Exhibition Expanded. More Exhibit Space Available. Contact us to Reserve Exhibit Space or be a Sponsor.

Tel: 86-21-5108 1591  |  E-mail: DLiu@slas.org

Sponsors:

Media Partners: